Pharmaceutical
This function is exclusive for Premium subscribers
-
DATABASE (45)
-
ARTICLES (22)
Proxima Ventures was founded in 2016 in Shanghai. It manages both RMB and US dollar funds, worth around US$150m in total. The firm invests mainly in early-stage startups in the healthcare sector. It has invested in 18 companies and established six innovation centers to incubate medtech startups.
Proxima Ventures was founded in 2016 in Shanghai. It manages both RMB and US dollar funds, worth around US$150m in total. The firm invests mainly in early-stage startups in the healthcare sector. It has invested in 18 companies and established six innovation centers to incubate medtech startups.
Yueyin Venture Capital was founded in 2015 in Beijing. It manages total assets worth US$300m, with investments in 22 companies. The VC focuses mainly in the healthcare, pharmaceutical and biotech sectors.
Yueyin Venture Capital was founded in 2015 in Beijing. It manages total assets worth US$300m, with investments in 22 companies. The VC focuses mainly in the healthcare, pharmaceutical and biotech sectors.
Haibang Fund was created in 2011 by Haibang Venture based in Hangzhou. Haibang Fund manages total assets worth US$360m with investments in 60 companies, four of which have gone public. Started by a group of overseas returnees and experienced investors, the VC focuses on startups founded by returnees from overseas.
Haibang Fund was created in 2011 by Haibang Venture based in Hangzhou. Haibang Fund manages total assets worth US$360m with investments in 60 companies, four of which have gone public. Started by a group of overseas returnees and experienced investors, the VC focuses on startups founded by returnees from overseas.
Renhe Group was founded in Jiangxi Province by Yang Wenlong in 2001. The group, including its flagship listed Renhe Pharmacy, earned total sales revenue of RMB 11.23bn in 2018 with a year-on-year profit growth of 25%. The group comprises 20 subsidiaries dealing in cosmetics, household chemicals, pharmaceutical, medical supplies and equipment.
Renhe Group was founded in Jiangxi Province by Yang Wenlong in 2001. The group, including its flagship listed Renhe Pharmacy, earned total sales revenue of RMB 11.23bn in 2018 with a year-on-year profit growth of 25%. The group comprises 20 subsidiaries dealing in cosmetics, household chemicals, pharmaceutical, medical supplies and equipment.
Junrun Capital was founded in 2009 in Ningbo, Zhejiang province. It's the largest private equity fund in Ningbo and specializes in M&A, equity and venture capital investments. So far, it has successfully exited seven deals out of a total of 21. Junrun has investment managers and researchers with backgrounds in science and technology. It has offices in Hangzhou, Shanghai, Shenzhen and the US. The company mainly seeks investment opportunities in sustainable materials, cleantech, agriculture, manufacture, biotechnology and the dotcom economy.
Junrun Capital was founded in 2009 in Ningbo, Zhejiang province. It's the largest private equity fund in Ningbo and specializes in M&A, equity and venture capital investments. So far, it has successfully exited seven deals out of a total of 21. Junrun has investment managers and researchers with backgrounds in science and technology. It has offices in Hangzhou, Shanghai, Shenzhen and the US. The company mainly seeks investment opportunities in sustainable materials, cleantech, agriculture, manufacture, biotechnology and the dotcom economy.
SFund, aka Guangzhou Industrial Investment Fund Management Co Ltd, was established in March 2013 by the Guangzhou Municipal Government to boost industrial upgrading in the city. Its business covers government fund management, private equity investment and venture capital investment.In July 2018, SFund became a subsidiary of Guangzhou City Construction Investment Group. The decision was made by the Guangzhou Municipal Government and the State-owned Assets Supervision and Administration Commission of the State Council.SFund has set up seven funds, managing total assets worth RMB 139bn. It has invested in 343 companies, 13 of which have become public-listed.
SFund, aka Guangzhou Industrial Investment Fund Management Co Ltd, was established in March 2013 by the Guangzhou Municipal Government to boost industrial upgrading in the city. Its business covers government fund management, private equity investment and venture capital investment.In July 2018, SFund became a subsidiary of Guangzhou City Construction Investment Group. The decision was made by the Guangzhou Municipal Government and the State-owned Assets Supervision and Administration Commission of the State Council.SFund has set up seven funds, managing total assets worth RMB 139bn. It has invested in 343 companies, 13 of which have become public-listed.
Founded in Beijing in 2015, Frees Fund is an asset management company with a portfolio valued at RMB 3.6bn. Frees primarily invests in early-stage startups in diverse sectors including fintech, education, healthcare, entertainment, hardware, intelligent manufacturing and SaaS. The VC is incorporated as Shanghai Ziyou Investment Management Co Ltd.
Founded in Beijing in 2015, Frees Fund is an asset management company with a portfolio valued at RMB 3.6bn. Frees primarily invests in early-stage startups in diverse sectors including fintech, education, healthcare, entertainment, hardware, intelligent manufacturing and SaaS. The VC is incorporated as Shanghai Ziyou Investment Management Co Ltd.
GF Qianhe is an equity investment company launched by GF Securities in May 2012. Incorporated as Guangfa Qianhe Investments Co Ltd, with a registered capital of RMB 500m, the company was one of the earliest alternative investment companies to gain approval from the Securities Commission of China. As of late 2018, GF Qianhe has invested in 86 equity-related projects, among which four have gone public. By the end of 2014, its total investment value reached almost RMB 2bn and revenues of over RMB 340m.
GF Qianhe is an equity investment company launched by GF Securities in May 2012. Incorporated as Guangfa Qianhe Investments Co Ltd, with a registered capital of RMB 500m, the company was one of the earliest alternative investment companies to gain approval from the Securities Commission of China. As of late 2018, GF Qianhe has invested in 86 equity-related projects, among which four have gone public. By the end of 2014, its total investment value reached almost RMB 2bn and revenues of over RMB 340m.
Founded in 2014, Prosperico Ventures targets the healthcare sector. The VC has invested in nearly 30 startups working on medical devices, pharmaceutical R&D, provision of medical services and precision medicine.
Founded in 2014, Prosperico Ventures targets the healthcare sector. The VC has invested in nearly 30 startups working on medical devices, pharmaceutical R&D, provision of medical services and precision medicine.
Shenzhen Guozhong Venture Capital Management Co., Ltd. (GZVCM)
Shenzhen Guozhong Venture Capital Management Co., Ltd. (GZVCM) was founded in December 2015. Chief Partner and CEO Shi Anping previously served as vice president at Shenzhen Venture Capital Group. GZVCM is currently entrusted to operate the state-backed Small Medium Enterprises Development Fund, which has RMB 60bn under management.
Shenzhen Guozhong Venture Capital Management Co., Ltd. (GZVCM) was founded in December 2015. Chief Partner and CEO Shi Anping previously served as vice president at Shenzhen Venture Capital Group. GZVCM is currently entrusted to operate the state-backed Small Medium Enterprises Development Fund, which has RMB 60bn under management.
Headquartered in Shanghai, FC Capital was founded in 2017 to focus on investments in China and the US. The VC mainly invests in medtech sectors like biotechnology, medical devices, medical services and health-related consumer products.
Headquartered in Shanghai, FC Capital was founded in 2017 to focus on investments in China and the US. The VC mainly invests in medtech sectors like biotechnology, medical devices, medical services and health-related consumer products.
Baiyang Capital was founded in 2014 by BAHEAL Pharmaceutical Holdings Limited and several senior professionals in the pharmaceutical and healthcare fields. The investment management company operates multiple funds, targeting pharmaceutical and healthcare businesses.
Baiyang Capital was founded in 2014 by BAHEAL Pharmaceutical Holdings Limited and several senior professionals in the pharmaceutical and healthcare fields. The investment management company operates multiple funds, targeting pharmaceutical and healthcare businesses.
Zhongguancun Longmen Investment
Investing in hi-tech IT, advanced manufacturing and biotechnology sectors – key pillars of China’s innovation-focused economy since 2017 – the Beijing government-backed Beijing Zhongguancun Longmen Investment manages about RMB 10bn via its first fund of the same name. The firm is founded and led by Xu Jinghong, former Chairman of Tsinghua Holdings, the investment and tech/R&D transfer arm of China’s most prestigious science and research university, whose R&D capacity was ranked in the third place of China’s top 500 enterprises in 2018. The LPs of the fund include social security funds, Beijing’s municipal government and the Haidian District government. Its portfolio enterprises are generally ranked in the top three of their respective industries. Among them, Qi An Xin Technology, which is listed in Shanghai and one of China’s biggest cybersecurity companies; Joy Wing Mao, one of China’s major fruits supply chain companies. In October of 2020, it invested RMB 100m into Beijing Immunochina Pharmaceutical, which develops innovative gene and cell therapies for curing malignant tumors. Longmen also provides mentoring and other expertise and support to its investee startups, especially those that plan to seek public listing.
Investing in hi-tech IT, advanced manufacturing and biotechnology sectors – key pillars of China’s innovation-focused economy since 2017 – the Beijing government-backed Beijing Zhongguancun Longmen Investment manages about RMB 10bn via its first fund of the same name. The firm is founded and led by Xu Jinghong, former Chairman of Tsinghua Holdings, the investment and tech/R&D transfer arm of China’s most prestigious science and research university, whose R&D capacity was ranked in the third place of China’s top 500 enterprises in 2018. The LPs of the fund include social security funds, Beijing’s municipal government and the Haidian District government. Its portfolio enterprises are generally ranked in the top three of their respective industries. Among them, Qi An Xin Technology, which is listed in Shanghai and one of China’s biggest cybersecurity companies; Joy Wing Mao, one of China’s major fruits supply chain companies. In October of 2020, it invested RMB 100m into Beijing Immunochina Pharmaceutical, which develops innovative gene and cell therapies for curing malignant tumors. Longmen also provides mentoring and other expertise and support to its investee startups, especially those that plan to seek public listing.
SoftBank announced its second Vision Fund of about $108bn in July 2019 to invest in technology startups across the world. SoftBank had originally planned to contribute $38bn to the new fund. However, its Vision Fund I was badly affected by the Covid-19 pandemic and losses resulting in lower valuations of its investments in Uber and WeWork.In February 2020, the Japanese conglomerate decided to inject more money into the Vision Fund II before raising new funds from other LPs. With $10bn committed to the second fund by the SoftBank Group, the new fund has now invested in 13 portfolio companies including co-leading the Series C round for XAG in November 2020.
SoftBank announced its second Vision Fund of about $108bn in July 2019 to invest in technology startups across the world. SoftBank had originally planned to contribute $38bn to the new fund. However, its Vision Fund I was badly affected by the Covid-19 pandemic and losses resulting in lower valuations of its investments in Uber and WeWork.In February 2020, the Japanese conglomerate decided to inject more money into the Vision Fund II before raising new funds from other LPs. With $10bn committed to the second fund by the SoftBank Group, the new fund has now invested in 13 portfolio companies including co-leading the Series C round for XAG in November 2020.
Guangzhou Emerging Industry Development Fund
Guangzhou Emerging Industry Development Fund (Emerging Fund) is a wholly-owned subsidiary of Guangzhou Industrial Investment Fund Management Co Ltd (SFund).It was found in line with the Guangzhou Municipal Government’s industrial upgrade strategy, with the aim of pooling capital, projects and talents together in Guangzhou. The Emerging Fund currently manages a set of government-guided funds and direct investment funds. It also invests in several state-level guidance funds on behalf of the municipal government. It mainly invests in emerging sectors in manufacturing, information technology, service sectors, seed and related industries.
Guangzhou Emerging Industry Development Fund (Emerging Fund) is a wholly-owned subsidiary of Guangzhou Industrial Investment Fund Management Co Ltd (SFund).It was found in line with the Guangzhou Municipal Government’s industrial upgrade strategy, with the aim of pooling capital, projects and talents together in Guangzhou. The Emerging Fund currently manages a set of government-guided funds and direct investment funds. It also invests in several state-level guidance funds on behalf of the municipal government. It mainly invests in emerging sectors in manufacturing, information technology, service sectors, seed and related industries.
Sequoia China Seed Fund: Growing an era of deep-tech startups
Managing Partner Neil Shen wants to help deep-tech and enterprise tech startups get investments more easily, across quantum computing, semiconductors, synthetic biology and more
South Summit 2021: Martin Varavsky, Leandro Sigman on post-Covid healthcare trends
Serial entrepreneur Martin Varavsky and Insud Pharma Chairman Leandro Sigman share their thoughts and projections on the future of health tech
Sequoia Capital China holds steady with investments in healthcare, biotech and green economy
China’s most active investor increases bets on sectors beyond the consumer internet and edtech recently hurt by regulatory clampdown
Nuuk, the cooler box poised to disrupt cold chain logistics
Barcelona-based startup Groenlandia Tech has developed a smart cooler box to track and monitor biological samples, providing an extra layer of security and control during transport
Allozymes wants to supercharge manufacturing with engineered enzymes
The Future Food Asia 2021 award winner speeds up enzyme engineering from years to months, is already attracting clients and has just raised $5m seed funding
HumanITcare: Covid-19 spurs demand for telemedicine across Spain and beyond
The startup’s revenue is expected to exceed €10m by 2024 due to rapid digital transformation of healthcare services and a growing market for AI-powered medtechs
iLoF: Accelerating access to personalized medicine, from a drop of blood
Backed by Microsoft’s venture fund M12, Mayfield and Melinda Gates’s Pivotal Ventures, iLoF focuses on painless screening to facilitate disease detection, forecasting and drug development, from Alzheimer’s to Covid-19
Xu Jinghong: Champion of young entrepreneurs and high-tech startups
Under Xu Jinghong’s leadership, Tsinghua Holdings grew its assets sevenfold and incubated over 10,000 businesses. In his new role as VC investor, Xu wants to nurture startups into future global leaders
agroSingularity: Turning discarded fruits and vegetables into usable powder to fix food waste
Closing €1.2m new funding will help the Murcia-based foodtech to build its own technology and facilities, expand into new markets
IOMED: Delivering structured, extractable patient big data and helping Spain's Covid-19 response
The medtech cuts the time spent on finding candidates for medical research by 90% and last month secured €2m in seed funding to take its software overseas
Early Charm Ventures: Taking research from the labs to the real world
Instead of investing money, the venture studio gets hands-on, co-running companies with top scientists and their cutting-edge research
Nucaps Nanotechnology: New encapsulation tech for nutritional and pharmaceutical sectors
Nucaps Nanotechnology is growing through a mix of accelerating market penetration and continuous R&D
More Asian men are into skincare and health products, and Elio is here to help (discreetly)
Elio believes offering privacy, free online consultations and discreet product packaging will encourage more men to take better care of their health
Spanish startups protest the lack of relevant aid, compared with other EU countries; investors warn of “disastrous” new foreign investment restriction
China's WeDoctor offers free coronavirus consultations globally in English and Chinese
WeDoctor lets anyone in the world send queries to doctors who fought to save lives in China's most affected Covid-19 districts, and now helping people overseas to stay safe during the pandemic
- 1
- 2
POPULAR DATABASE
